Literature DB >> 2031174

Haemolytic uraemic syndrome: 17 years' experience in a Scottish paediatric renal unit.

D A Hughes1, T J Beattie, A V Murphy.   

Abstract

Seventy-nine children with the Haemolytic Uraemic Syndrome were referred to our unit between 1972 and 1988. The typical summer peak incidence was seen. A diarrhoeal prodrome occurred in 71 (90%). Fifty-nine (75%) required dialysis and 74 (94%) blood transfusion. Extra-renal disease was documented: neurological 32 (40%); abdominal 11 (14%); diabetes mellitus one case. Fifty-one (61%) had acute hypertension. The acute mortality rate was 9%. Children with neurological features had greater biochemical disturbances and longer duration of dialysis. Fifty-nine children were followed for a mean 47.4 months. Forty-four (75%) are healthy. Nine (15%) have renal impairment, two have proteinuria, one hypertension and one has a residual hemiparesis. There were two late deaths. Presence of acute neurological features increased risk of early death or survival with sequelae. Prolonged dialysis was significantly associated with poorer outcome. However, there were no reliable early indicators of poor prognosis.

Entities:  

Mesh:

Year:  1991        PMID: 2031174     DOI: 10.1177/003693309103600105

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  6 in total

1.  Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.

Authors:  D J Stearns-Kurosawa; Valta Collins; Scott Freeman; Vernon L Tesh; Shinichiro Kurosawa
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 2.  Management of diarrhea-associated hemolytic uremic syndrome in children.

Authors:  Kazumoto Iijima; Ichiro Kamioka; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

3.  Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.

Authors:  Fumiko Obata; Koujiro Tohyama; Adrian D Bonev; Glynis L Kolling; Tiffany R Keepers; Lisa K Gross; Mark T Nelson; Shigehiro Sato; Tom G Obrig
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

Review 4.  Protection against Shiga Toxins.

Authors:  Simona Kavaliauskiene; Anne Berit Dyve Lingelem; Tore Skotland; Kirsten Sandvig
Journal:  Toxins (Basel)       Date:  2017-02-03       Impact factor: 4.546

5.  Hemolytic-uremic syndrome in asir region.

Authors:  N N Al Harbi; M E Elawad; M A Al Homrany
Journal:  J Family Community Med       Date:  1996-01

6.  Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study.

Authors:  Sebastian Ullrich; Phillip Bremer; Christine Neumann-Grutzeck; Helge Otto; Christoph Rüther; Cay Uwe von Seydewitz; Gerd Peter Meyer; Keihan Ahmadi-Simab; Joachim Röther; Barbara Hogan; Wolfgang Schwenk; Roman Fischbach; Jörg Caselitz; Jochen Puttfarcken; Susanne Huggett; Petra Tiedeken; Jordan Pober; Nancy C Kirkiles-Smith; Friedrich Hagenmüller
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.